Onyx Embolization for Isolated Type Dural Arteriovenous Fistula Using a Dual-Lumen Balloon Catheter

Neurosurgery. 2016 May;78(5):627-36. doi: 10.1227/NEU.0000000000001069.

Abstract

Background: Utilization of a dual-lumen balloon may improve Onyx penetration into isolated dural arteriovenous fistulas (i-DAVFs).

Objective: To compare the results of Onyx embolization using a dual-lumen balloon with those using a non-balloon catheter for i-DAVFs.

Methods: Twenty-nine patients underwent Onyx embolization for i-DAVFs using a non-balloon (n = 14) or a dual-lumen balloon catheter (n = 15). Since its introduction, a dual-lumen balloon catheter has been preferred. We compared the dual-lumen balloon group with the non-balloon catheter group regarding angiographic outcome, treatment-related complications, total procedural time, Onyx injection time, and the number of feeders requiring embolization.

Results: The dual-lumen balloon group showed complete occlusion of i-DAVFs in 13 and near-complete in 2 patients, while the non-balloon group showed complete occlusion in 5, near-complete in 5, and incomplete in 4 patients (P < .05). Treatment-related complications occurred in 2 patients: 1 in the non-balloon group and 1 in the dual-lumen balloon group. The mean total procedural time was 62 ± 32 minutes in the dual-lumen balloon and 171 ± 88 minutes in the non-balloon group (P < .05). The mean Onyx injection time was 10 ± 6 minutes in the dual-lumen balloon and 49 ± 32 minutes in the non-balloon group (P < .05). The median number of feeders requiring embolization was 1 (range, 1-3) in the dual-lumen balloon and 2 (range, 1-4) in the non-balloon group (P < .05).

Conclusion: Utilization of a dual-lumen balloon catheter for Onyx embolization of i-DAVF seemed to significantly increase the immediate complete occlusion rate and decrease total procedural time, Onyx injection time, and number of feeders requiring embolization.

MeSH terms

  • Adult
  • Aged
  • Balloon Embolectomy / methods*
  • Catheterization
  • Catheters
  • Central Nervous System Vascular Malformations / therapy*
  • Dimethyl Sulfoxide*
  • Embolization, Therapeutic / methods*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polyvinyls*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Onyx copolymer
  • Polyvinyls
  • Dimethyl Sulfoxide